Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001233368 | SCV001405958 | uncertain significance | Congenital myasthenic syndrome 4A | 2023-07-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CHRNE protein function. ClinVar contains an entry for this variant (Variation ID: 959930). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 207 of the CHRNE protein (p.Ile207Val). |
Natera, |
RCV001834024 | SCV002093421 | uncertain significance | Congenital myasthenic syndrome | 2020-03-11 | no assertion criteria provided | clinical testing |